vorinostat has been researched along with Cancer of Gallbladder in 3 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, S | 1 |
| Li, F | 1 |
| Pan, L | 1 |
| Yang, Z | 1 |
| Shu, Y | 1 |
| Lv, W | 1 |
| Dong, P | 1 |
| Gong, W | 1 |
| Zhang, P | 2 |
| Guo, Z | 1 |
| Wu, Y | 1 |
| Hu, R | 1 |
| Du, J | 2 |
| He, X | 1 |
| Jiao, X | 2 |
| Zhu, X | 1 |
| Jiang, G | 1 |
| Gao, J | 1 |
| Li, L | 1 |
3 other studies available for vorinostat and Cancer of Gallbladder
| Article | Year |
|---|---|
BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Divisio | 2019 |
Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D1; G1 Phase Cell Cyc | 2015 |
SAHA down-regulates the expression of indoleamine 2,3-dioxygenase via inhibition of the JAK/STAT1 signaling pathway in gallbladder carcinoma cells.
Topics: Antineoplastic Agents; Antiviral Agents; Blotting, Western; Gallbladder Neoplasms; Gene Expression R | 2013 |